Leading digital healthcare platform Doximity rocketed past analysts' expectations, but offered up disappointing guidance. Shares of the leading digital platform for U.S. medical professionals, Doximity (NYSE: DOCS), were down 14% as of noon ET Friday, according to data provided by S&P Global Market Intelligence. Doximity wrapped up its fiscal 2025 on Friday, delivering revenue and free cash flow (FCF) growth of 20% and 50%, respectively, during the year.